Solvent-free desymmetrisation of a meso-dialdehyde with chiral alcohols, led to preparation of 4-silyloxy-6-alkyloxytetrahydro-2H-pyran-2-one derivatives with a 96% de. This methodology, which yields the corresponding methyl nor-mevaldates with 99% ee, has been applied to the enantioselective synthesis of the (À)-(R) and (þ)-(S) nor-mevalonic acid lactones.
Introduction
Enantioselective desymmetrisation of meso or prochiral compounds has become a powerful tool in the preparation of enantiomerically pure compounds, 1 using chiral reagents, enzymes 2 or catalysts. 3 Symmetrical or achiral precursors may provide a synthetic advantage by permitting inclusion of a certain degree of complexity before introducing chirality at the desymmetrisation step, instead of incorporating chirality at very early steps of a synthesis. This approach has been successfully applied to the desymmetrisation of a range of substrates such as dienes, 4 meso-anhydrides, 5 meso-diols 6 and meso-dialdehydes. Desymmetrisation of meso-dialdehydes has been performed via HornereWadswortheEmmons reaction, 7 alkylation, 8 carbonyl-ene cyclisation reaction 9 and aldol condensation, either using chiral reagents, 10 an organometallic catalyst 11 or organocatalysis. 12 In this respect, the synthetic utility of 1,3,5-trioxygenated substrates has led to much interest in their enantiocontrolled preparation. 13 For instance, enantiomerically pure methyl normevaldate 1 has been used as a building block for the synthesis of bioactive molecules such as b-hydroxyacids with antifungal activity, 14 HMG-CoA reductase inhibitors 15 or analogues of statins 16 and 6-alkyl-4-hydroxypyran-2-ones 17 with oestrogenic activity.
Furthermore, diverse mevalonic lactone analogues with different substituents in position 4 have been recently synthesised and reported as inhibitors of the mevalonate pathway in the bacterium Streptococcus pneumoniae.
18
As part of our strategy for the design of antifungal agents against Botrytis and Colletotrichum species, 19 we have recently reported the preparation of 4-hydroxy-6-(1-phenylethoxy)tetrahydro-2H-pyran-2-one (2) as a selective antifungal agent against the phytopathogen Botrytis cinerea via the desymmetrisation reaction of a suitable meso-dialdehyde precursor 3 with chiral phenylethanol. 20, 21 In this paper we extend this methodology to the preparation of a range of 6-alkyloxy-4-silyloxytetrahydro-2H-pyran-2-ones using different chiral alcohols. The use of the dialdehyde 3 as a building block for the enantioselective preparation of 1,3,5-trioxygenated substrates related to methyl nor-mevaldate 1, such as normevalonic acid lactones (À)-(R)-4 and (þ)-(S)-5 is also described (Fig. 1) . These compounds are of interest for structureeactivity relationship (SAR) studies.
Results and discussion

Optimisation of desymmetrisation reaction
The absolute stereochemistries of chiral 6-arylalkyloxy-4-silyloxytetrahydro-2H-pyran-2-ones (þ)-6a and (þ)-6b were established unequivocally in previous reports by a combination of X-ray crystallographic analyses of the structurally related tetrahydro-2H-pyran-2-ones (þ)-7a and (À)-7c, NOE difference studies and chemical correlation of tetrahydro-2H-pyran-2-ones (þ)-6a and (þ)-7a with (À)-(R) methyl 3-(tert-butyldimethylsilyloxy)-5-oxopentanoate (8) and of tetrahydro-2H-pyran-2-ones (þ)-6b and (À)-7c with (þ)-(S) methyl 3-(tert-butyldimethylsilyloxy)-5-oxopentanoate 9 (Scheme 1). 21 Evaluation of the influence of the chiral alcohol structure on the diastereoselectivity of the desymmetrisation process was then undertaken. Consequently, solvent-free conditions, 20 which have been shown to lead to better selectivity than the use of dry THF for the preparation of lactone (þ)-6a, 21 were applied to a series of commercially available chiral alcohols 10e14, achieving an optimal 14.7% overall yield and 96% de with (þ)-(R) or (À)-(S)-1-(naphthalen-2-yl)ethanol (Schemes 2 and 3, Table 1 , entry 6). Best yields and de were obtained when 1-arylethanols were used as chiral auxiliaries (6 and 14) , suggesting that efficient desymmetrisation required not only a stereogenic centre directly attached to the hydroxyl group, but also a large aromatic group attached to the stereogenic centre, as use of (À)-myrtenol resulted in no asymmetric induction (Table 1 , entry 4). Scheme 2. Solvent-free desymmetrisation of dialdehyde 3 with different chiral alcohols.
Scheme 3. Preparation of (À)-15a and (À)-15b via solvent-free desymmetrisation of dialdehyde 3 with (À)-(S)-1-(naphthalen-2-yl)ethanol.
Stereochemistries of the compounds 10ae14a, 10ce13c and 14b were established by a combination of NOESY studies, analysis of 1 H NMR coupling constants and comparison with related lactones 6a, 6b, 7a and 7c, whose absolute stereochemistries have been reported before. 21 For example, compound (þ)-14a presented spectroscopic data closely related to those for compound 6a, but significantly different to those for compounds 6b and 7c, while compound 14b presented spectroscopic data closely related to those for compound 6b. Such correlations and the NOE. enhancement observed between H-6 and H-4 for 14b allowed us to assign their structures as (4R,6S)-4-((tert-butyldimethylsilyl) oxy)-6-((R)-1-(naphthalen-2-yl)ethoxy)tetrahydro-2H-pyran-2-one (þ)-14a and (4S,6S)-4-((tert-butyldimethylsilyl)oxy)-6-((R)-1-(naphthalen-2-yl)ethoxy)tetrahydro-2H-pyran-2-one (þ)-14b, respectively ( 1 H NMR data for compounds 6a,b, 7a, 10ae14a and 14b are presented in Tables 2 and 3 ; 1 H NMR data for compounds 7c and 10ce13c in Table 4 ; 13 C NMR data for compounds 6a,b, 7a, 10ae14a, 14b, 7c and 10ce13c in Tables S1eS3 of Supplementary data). 
a Yields obtained after chromatographic purification. 
Preparation of nor-mevalonic acid lactones (L)-(R)-4 and (D)-(S)-5
To exemplify the utility of our methodology, and in order to prepare reference compounds for SAR studies, 18 
Conclusions
In summary, the optimization of the desymmetrisation of meso dialdehyde 3 led to the selective preparation of (þ)-(4R,6S)-4-((tert-butyldimethylsilyl)oxy)-6-((R)-1-(naphthalen-2-yl)ethoxy) tetrahydro-2H-pyran-2-one (14a) and (4S,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((S)-1-(naphthalen-2-yl)ethoxy)tetrahydro-2H-pyran-2-one-(15a) in 96% de when either (R)-(þ)-1-(naphthalen-2-yl)ethanol or (S)-(À)-1-(naphthalen-2-yl)ethanol was used under solvent-free conditions at room temperature. HPLC purification and methanolysis of (þ)-(4R,6S,
, respectively, in 99% ee. Further transformation of these substrates allowed the enantioselective preparation of the nor-mevalonic acid lactones (À)-(R)-4 and (þ)-(S)-5 (in 42% overall yield and 79% ee and in 41% overall yield and 96% ee, respectively).
Experimental section
General
Unless otherwise noted, materials and reagents were obtained from commercial suppliers and were used without further purification. Dichloromethane was freshly distilled from CaH 2 and tetrahydrofuran was dried over sodium and benzophenone and freshly distilled before use. Air-and moisture-sensitive reactions were performed under an argon atmosphere. Purification by semipreparative and analytical HPLC was performed, respectively, with 250 mmÂ10 mm (10 mm particles) and 250 mmÂ4 mm (5 mm particles) columns using a differential refractometer detector. Silica gel was used for column chromatography. TLC analyses were performed on aluminium plates coated with silica gel with fluorescent indicator (254 nm), 0.25 mm thick. Enantiomeric excesses (ee) were measured by GC using a Cyclosil B chiral column (30 m lengthÂ0.25 mm ID, 0.25 mm film thickness), using an FID detector at 320 C, a split injector (15:1 ratio) at 250 C, hydrogen as carrier at 10 psi and 1 mL of injection volume. Temperature program is described in the experimental section for every relevant compound. Specific rotations were determined with a digital polarimeter. Infrared spectra were recorded on an FTIR spectrophotometer and peak position reported in wavenumbers (cm À1 ). 1 H spectra were recorded on spectrometers operating at 300 and 400 MHz. and 2D techniques. Multiplicities are described using the following abbreviations: s¼singlet, d¼doublet, t¼triplet, q¼quartet; quint¼quintet; sext¼sextet; m¼multiplet, br¼broad. Highresolution mass spectrometry (HRMS) was recorded with a double-focussing magnetic sector mass spectrometer in positive ion mode, or in a QTOF mass spectrometer in positive ion electrospray mode at 20 V cone voltage.
Procedures
4.2.1. General procedure for the preparation of 6-alkyloxy-4-(tertbutyldimethylsilyloxy)tetrahydro-2H-pyran-2-ones (6a,b, 10ae15a, 14b, 15b and 10ce13c): desymmetrisation of 3-(tert-butyldimethylsilyloxy)pentanedial (3) under solvent-free conditions followed by PCC oxidation. The requisite alcohol (see Schemes 2 and 3 of the manuscript) (2.9 mmol) was added to a mixture of 3-(tert-butyldimethylsilyloxy)pentanedial (3) (1 mmol) 20 and 4 A molecular sieves (0.5 g for each mmol of 3) under an argon atmosphere and the mixture stirred for 24 h. The slurry was dissolved in CH 2 Cl 2 (20 mL) and added dropwise to a suspension of PCC (3.5 mmol) and powdered molecular sieves 4 A (twice the weight of the alcohol) in dichloromethane (70 mL) at room temperature. The reaction mixture was stirred vigorously for 18 h, diethyl ether was then added (200 mL) and the mixture was stirred for a further 1 h. The suspension was filtered through a pad of silica gel and washed through with a further quantity of ether (200 mL). The ether was removed under reduced pressure to give the crude mixture of tetrahydro-2H-pyran-2-ones, which was purified by column chromatography (petroleum ether/Et 2 O, 90:10), to yield the corresponding tetrahydro-2H-pyran-2-ones in the ratios and yields shown below and in Table 1 and Schemes 2 and 3 of the manuscript. Table 3 ); 13 C NMR (CDCl 3, 100 MHz) (see 1R,2S,5R )-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)oxy)tetrahydro-2H-pyran-2-one (10c). Yield 1.5 mg, 0.4%. Colourless oil; HPLC t R ¼26 min (petroleum ether/ethyl acetate 93:7; flow¼3.0 mL/min); [a] D 20 þ44.8 (c 0. Table 3 ); 13 C NMR (100 MHz, CDCl 3 ) (see Table S2 ); HRMS (see Table 4 ); 13 C NMR (100 MHz, CDCl 3 ) (see Table S3 ); HRMS Table 3 ); 13 C NMR (100 MHz, CDCl 3 ) (see Table S2 ); HRMS ( Table 4 ); 13 C NMR (100 MHz, CDCl 3 ) (see Table S3 ); HRMS ( ; 1 H NMR (400 MHz, CDCl 3 ) (see Table 2 ); 13 C NMR (100 MHz, CDCl 3 ) (see Table S1 
(À)-(4R(S),6S(R))-4-((tert-Butyldimethylsilyl)oxy)-6-(((1R,2S,5R)-5-methyl-2-(prop-1-en-2-yl)cyclohexyl)oxy)tetrahydro-2H-pyran-2-one (10a
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,CI þ ): m/z [MþH] þ ,CI þ ): m/z [MþH] þ ,found4.2.1.10. (þ)-(4S,6S)-4-((tert-Butyldimethylsilyl)oxy)-6-((R)-1- (naphthalen-2-yl)ethoxy)tetrahydro-2H-pyran-2-one (14b
Preparation of (À)-(R)-Methyl 3-(tert-butyldimethylsilyloxy)-5-oxopentanoate ((À)-(R)-8).
Sodium methoxide (654.5 mg, 12.12 mmol) was added to a solution of tetrahydro-2H-pyran-2-one (þ)-14a (809.0 mg, 2.02 mmol) in dry MeOH (101 mL) at À35 C. The reaction mixture was stirred at À35 C for 24 h, then quenched with saturated NH 4 Cl (110 mL). The mixture was then allowed to warm to room temperature and diethyl ether (300 mL) was added. The layers were separated and the aqueous phase was further extracted with diethyl ether (3Â300 mL). The combined organic layers were washed with brine (2Â500 mL), dried over Na 2 SO 4 The enantiomeric excess of 9 could be determined by chiral gas chromatography, using the general conditions stated above; isocratic 80 C. t R (min): 256.19.
Preparation of (À)-(R)-methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxypentanoate ((R)-16).
Sodium borohydride (28.5 mg, 0.75 mmol) was added to a solution of (R)-8 (153.7 mg, 0.59 mmol) in dry MeOH (101 mL) at À35 C under an argon atmosphere. The reaction mixture was stirred at À35 C for 24 h, adding two supplementary portions of NaBH 4 (15 mg each portion). Then, 1 M HCl was added until pH 7 (8 mL) and the reaction mixture was allowed to warm to room temperature. Solvent was removed under reduced pressure and ethyl acetate (50 mL) and brine (15 mL) were added. The layers were separated and the aqueous layer was further extracted with ethyl acetate (3Â50 mL). The combined organic layers were washed with brine (100 mL), dried over Na 2 SO 4 
Preparation of (À)-(R)-4-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-one ((R)-17)
. p-Toluenesulfonic acid monohydrate (PTSA) (1.8 mg, 0.01 mmol) was added to a solution of (À)-(R)-methyl 3-(tert-butyldimethylsilyloxy)-5-hydroxypentanoate ((R)-16) (38.0 mg, 0.15 mmol) in dry CH 2 Cl 2 (2.3 mL) at room temperature. When TLC analysis indicated the completion of the reaction (1 h), saturated NaHCO 3 was added (3 mL) and the mixture was stirred for a further 15 min. The aqueous phase was then extracted with ethyl acetate (3Â25 mL), the combined organic layers were washed with brine (50 mL), dried over Na 2 SO 4 and filtered. Evaporation of the solvent gave the crude product that was purified by silica gel column chromatography (petroleum ether/EtOAc 90:10), to yield (R)-17 (28.9 mg, 87%, 89% ee could be determined by chiral gas chromatography, using the general conditions stated above; isocratic 100 C. t R (min): 204.26 (major), 217.71 (minor).
